USRE35097EExpiredUtility

Gene for diagnosing cancer metastatic potential

31
Assignee: US HEALTHPriority: Oct 13, 1987Filed: Apr 6, 1993Granted: Nov 21, 1995
Est. expiryOct 13, 2007(expired)· nominal 20-yr term from priority
Inventors:Patricia S. SteegLance A. LiottaMark E. Sobel
Y10S436/813Y10S436/811C12Q 2600/112C12Q 2600/118C12N 9/12C12Q 1/6886C12Q 2600/158C07K 14/47
31
PatentIndex Score
2
Cited by
3
References
4
Claims

Abstract

A new NM23 gene and its relationship with metastatic potential of tumor cells is described.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. Isolated, synthetic NM23 gene. 
     
     
       2. The gene of claim 1 cloned in a cloning vector. 
     
     
       3. .[.The gene of claim 2.]. .Iadd.A clone .Iaddend.having the identifying characteristics of ATCC 67539. 
     
     
       4. NM23 gene having been recovered from the clone of claim 3.

Join the waitlist — get patent alerts

Track USRE35097E — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.